Manchester University has forged a partnership with San Diego-based Agena Bioscience to expand its educational resources in the field of pharmacogenomics. Pharmacogenomics is the study of how a person’s unique genetic makeup influences his or her response to medications.
Agena is a global provider of genetic testing solutions.
The university offers a Graduate Certificate in PGx and a Master of Science in PGx degree. Manchester says the programs help health care professionals to enhance their clinical knowledge of PGx.
“Our relationship with Agena stems from the mutual goal of expanding the awareness of pharmacogenetic testing and its importance to the future of precision medicine,” said W. Thomas Smith, dean of Pharmacy and Graduate Life Sciences at Manchester University. “We believe that pharmacogenomics will increasingly enable physicians and other clinicians to prescribe the right dose of the right medicine at the right time, which ultimately leads to better healthcare outcomes.”
Both the graduate certificate and master’s programs are taught on line by Manchester University faculty.